Novel 2,7-Naphthyridine Compounds as MASTL Inhibitors for Treating Cancer.

Provided herein are novel 2,7-naphthyridine compounds as MASTL inhibitors, pharmaceutical compositions, use of such compounds in treating cancer, and processes for preparing such compounds.